Clinical Trials in Ohtsu, Shiga
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
C3G
Novartis Pharmaceuticals98 enrolled87 locationsNCT04817618
Recruiting
Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals225 enrolled50 locationsNCT03955445
Recruiting
Fabhalta Capsules Specified Drug-use Survey
C3 Glomerulopathy
Novartis Pharmaceuticals50 enrolled26 locationsNCT07156149
Recruiting
Phase 3
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals31 enrolled15 locationsNCT06994845
Recruiting
Revolade Tablets Specified Drug-use Survey
Aplastic Anemia
Novartis Pharmaceuticals10 enrolled17 locationsNCT06287268